The estimated Net Worth of Michael Schamroth is at least $11.1 Million dollars as of 3 September 2019. Mr. Schamroth owns over 15,000 units of Biospecifics Technologies stock worth over $10,259,742 and over the last 15 years he sold BSTC stock worth over $588,160. In addition, he makes $202,507 as Independent Director at Biospecifics Technologies.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Schamroth BSTC stock SEC Form 4 insiders trading
Michael has made over 10 trades of the Biospecifics Technologies stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 15,000 units of BSTC stock worth $396,450 on 3 September 2019.
The largest trade he's ever made was exercising 24,000 units of Biospecifics Technologies stock on 24 August 2015 worth over $96,000. On average, Michael trades about 7,267 units every 137 days since 2009. As of 3 September 2019 he still owns at least 115,890 units of Biospecifics Technologies stock.
You can see the complete history of Mr. Schamroth stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Michael Schamroth biography
Michael Schamroth serves as Independent Director of the Company. He has been a partner of M. Schamroth & Sons in New York City for over 60 years. As a principal in this fourth-generation international diamond house, Mr. Schamroth has extensive experience in dealing with all aspects of the trade, from manufacturing to sales. He has been a member of the Diamond Manufacturers and Importers Association since 1964, and has served on the Nominating and Building Committees of the Diamond Dealers Club. In addition, Mr. Schamroth has served as a member of the board of South Nassau Communities Hospital since 1976 and the board of the Winthrop-South Nassau University Health System since 1993. He is a past chairman of the board in both hospital systems. Additionally, he has served on the board of Sound Bank of North Carolina since 2002. In serving the community, Mr. Schamroth founded SIBSPlace, now in its 20th year, to meet the needs of the well child in a family struggling with a devastating illness. Also, he has been Deputy Mayor and Police Commissioner of Hewlett Bay Park and a First Responder AMT for the Bellmore/Merrick Ambulance Corps. Committed to education, he has been a member of the Miami University Business Advisory Board since 1984 and served as its Chairman from 1987-1988. In the New York area, he revived the New York-Miami Alumni Club in 1965 and served as its President for 11 years. Mr. Schamroth received his B.S. in Business from Miami University, Oxford, Ohio.
What is the salary of Michael Schamroth?
As the Independent Director of Biospecifics Technologies, the total compensation of Michael Schamroth at Biospecifics Technologies is $202,507. There are 1 executives at Biospecifics Technologies getting paid more, with Jennifer Chao having the highest compensation of $217,507.
How old is Michael Schamroth?
Michael Schamroth is 80, he's been the Independent Director of Biospecifics Technologies since 2004. There are 1 older and 7 younger executives at Biospecifics Technologies. The oldest executive at Biospecifics Technologies Corp. is Toby Wegman, 85, who is the Director.
What's Michael Schamroth's mailing address?
Michael's mailing address filed with the SEC is 35 Wilbur St, Lynbrook, NY 11563, USA.
Insiders trading at Biospecifics Technologies
Over the last 33 years, insiders at Biospecifics Technologies have traded over $67,860,045 worth of Biospecifics Technologies stock and bought 7,761,661 units worth $656,708,120 . The most active insiders traders include Capital Management, Llc Kol..., International Plc Endo, and Max Link. On average, Biospecifics Technologies executives and independent directors trade stock every 73 days with the average trade being worth of $6,538,649. The most recent stock trade was executed by International Plc Endo on 2 December 2020, trading 7,344,955 units of BSTC stock currently worth $650,028,518.
What does Biospecifics Technologies's logo look like?
Complete history of Mr. Schamroth stock trades at Biospecifics Technologies
Biospecifics Technologies executives and stock owners
Biospecifics Technologies executives and other stock owners filed with the SEC include:
-
Jennifer Chao,
Independent Chairman of the Board -
Michael Schamroth,
Independent Director -
Paul Gitman,
Independent Director -
Mark Wegman,
Director -
Toby Wegman,
Director -
Sarah McCabe,
Stern Investor Relations -
Michael Sherman,
Independent Director -
Corey Fishman,
Independent Director -
Alex Monteith,
Senior Vice President and Chief Business Officer -
Patrick Hutchison,
Chief Financial Officer -
Joseph Truitt,
Chief Executive Officer, Director -
Jeffrey Kenneth Vogel,
-
Jyrki Mattila,
Director -
Thomas Wegman,
President -
Of Edwin H. Wegman Estate,
10% owner -
Patrick M Caldwell,
Principal Financial Officer -
Partners Lp Bio,
10% owner -
Albert Horcher,
-
Lawrence Dobroff,
CFO -
Max Link,
Director -
Henry Morgan,
Director -
George M Gould,
Director -
Matthew Geller,
Director -
Capital Management, Llc Kol...,
-
Capital Management, Llcra C...,
-
Capital Management, Llcaldr...,
-
Capital Management, Llc Kol...,
-
Capital Management, Llcra C...,
-
J Kevin Buchi,
Chief Executive Officer -
International Plc Endo,
10% owner